Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist

scientific article

Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1210/JC.84.4.1250
P698PubMed publication ID10199763
P5875ResearchGate publication ID13097986

P2093author name stringAdami S
Castello R
Gatti D
Moghetti P
Muggeo M
Negri C
Rossini M
Tosi F
Zamberlan N
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)1250-1254
P577publication date1999-04-01
P1433published inThe Journal of Clinical Endocrinology and MetabolismQ3186902
P1476titleSpironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist
P478volume84